These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28545152)

  • 1. Short-term changes in the health state of children with group B meningococcal disease: A prospective, national cohort study.
    Kennedy ITR; van Hoek AJ; Ribeiro S; Christensen H; Edmunds WJ; Ramsay ME; Ladhani SN
    PLoS One; 2017; 12(5):e0177082. PubMed ID: 28545152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequelae at Hospital Discharge in 61 Children With Invasive Meningococcal Disease, Chile, 2009-2019.
    Arteta-Acosta C; Villena Martínez R; Santolaya de Pablo ME
    Pediatr Infect Dis J; 2022 Aug; 41(8):607-613. PubMed ID: 35421054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Culture-Confirmed Invasive Meningococcal Disease in Canada, 2010 to 2014: Characterization of Serogroup B
    Tsang RSW; Law DKS; De Paola R; Giuliani M; Stella M; Zhou J; Deng S; Boccadifuoco G; Giuliani MM; Serino L
    mSphere; 2020 Mar; 5(2):. PubMed ID: 32132156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost-of-illness for invasive meningococcal disease caused by serogroup B Neisseria meningitidis (MenB) in Germany.
    Scholz S; Koerber F; Meszaros K; Fassbender RM; Ultsch B; Welte RR; Greiner W
    Vaccine; 2019 Mar; 37(12):1692-1701. PubMed ID: 30661834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness of 4CMenB Infant Vaccination in England: A Comprehensive Valuation Considering the Broad Impact of Serogroup B Invasive Meningococcal Disease.
    Beck E; Klint J; Neine M; Garcia S; Meszaros K
    Value Health; 2021 Jan; 24(1):91-104. PubMed ID: 33431159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The quality-adjusted life-years loss due to serogroup B invasive meningococcal disease in Spain.
    García A; Vallejo-Aparicio LA; Begum N; Nikitas G; González-Inchausti C; de Gomensoro E
    Vaccine; 2024 Sep; 42(22):126155. PubMed ID: 39146857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of illness of invasive meningococcal disease caused by serogroup B Neisseria meningitidis in Spain.
    Ivanova-Markova Y; González-Domínguez A; Hidalgo A; Sánchez R; García-Agua N; García-Ruiz AJ; Amanda Vallejo-Aparicio L; García A; Rodriguez R; de Gomensoro E; Gonzalez-Inchausti MDC; Shen J; Begum N; Tafalla M
    Vaccine; 2021 Dec; 39(52):7646-7654. PubMed ID: 34794819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease Burden of Invasive Meningococcal Disease in the Netherlands Between June 1999 and June 2011: A Subjective Role for Serogroup and Clonal Complex.
    Stoof SP; Rodenburg GD; Knol MJ; Rümke LW; Bovenkerk S; Berbers GA; Spanjaard L; van der Ende A; Sanders EA
    Clin Infect Dis; 2015 Oct; 61(8):1281-92. PubMed ID: 26123933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study.
    Hill DM; Lucidarme J; Gray SJ; Newbold LS; Ure R; Brehony C; Harrison OB; Bray JE; Jolley KA; Bratcher HB; Parkhill J; Tang CM; Borrow R; Maiden MC
    Lancet Infect Dis; 2015 Dec; 15(12):1420-8. PubMed ID: 26515523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Be on the TEAM' Study (Teenagers Against Meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescents.
    Carr J; Plested E; Aley P; Camara S; Davis K; MacLennan JM; Gray S; Faust SN; Borrow R; Christensen H; Trotter C; Maiden MCJ; Finn A; Snape MD;
    BMJ Open; 2020 Oct; 10(10):e037358. PubMed ID: 33093030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study.
    Viner RM; Booy R; Johnson H; Edmunds WJ; Hudson L; Bedford H; Kaczmarski E; Rajput K; Ramsay M; Christie D
    Lancet Neurol; 2012 Sep; 11(9):774-83. PubMed ID: 22863608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Health Burden of Invasive Meningococcal Disease: A Systematic Review.
    Strifler L; Morris SK; Dang V; Tu HA; Minhas RS; Jamieson FB; Deeks SL; Crowcroft NS; Sander B
    J Pediatric Infect Dis Soc; 2016 Dec; 5(4):417-430. PubMed ID: 26501470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B
    Mulhall RM; Bennett D; Cunney R; Borrow R; Lucidarme J; Findlow J; Jolley KA; Bray J; Maiden MCJ; Moschioni M; Serino L; Stella M; Medini D
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30135218
    [No Abstract]   [Full Text] [Related]  

  • 14. Interpreting parental proxy reports of (health-related) quality of life for children with unilateral cochlear implants.
    Sach TH; Barton GR
    Int J Pediatr Otorhinolaryngol; 2007 Mar; 71(3):435-45. PubMed ID: 17161471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inpatient costs and hospital service use associated with invasive meningococcal disease in South Australian children.
    Wang B; Haji Ali Afzali H; Marshall H
    Vaccine; 2014 Aug; 32(37):4791-8. PubMed ID: 24998605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review of the Epidemiology of Invasive Meningococcal Disease and Vaccination Strategies in North Africa.
    Taha MK; Presa J; Serra L
    Int J Infect Dis; 2021 Mar; 104():189-197. PubMed ID: 33227521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive meningococcal disease: Timing and cause of death in England, 2008-2015.
    Beebeejaun K; Parikh SR; Campbell H; Gray S; Borrow R; Ramsay ME; Ladhani SN
    J Infect; 2020 Mar; 80(3):286-290. PubMed ID: 31904388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of invasive meningococcal B disease in Australia, 1999-2015: priority populations for vaccination.
    Archer BN; Chiu CK; Jayasinghe SH; Richmond PC; McVernon J; Lahra MM; Andrews RM; McIntyre PB;
    Med J Aust; 2017 Nov; 207(9):382-387. PubMed ID: 29092704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales.
    Ladhani SN; Beebeejaun K; Lucidarme J; Campbell H; Gray S; Kaczmarski E; Ramsay ME; Borrow R
    Clin Infect Dis; 2015 Feb; 60(4):578-85. PubMed ID: 25389259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative long-term adverse effects elicited by invasive group B and C meningococcal infections.
    Gottfredsson M; Reynisson IK; Ingvarsson RF; Kristjansdottir H; Nardini MV; Sigurdsson JF; Schneerson R; Robbins JB; Miller MA
    Clin Infect Dis; 2011 Nov; 53(9):e117-24. PubMed ID: 21946191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.